Health Highlights: July 18, 2009

While Dr. Otis W. Brawley, the American Cancer Society's chief medical officer, called Collins "an extraordinary scientist and one of the nicest guys you could ever meet," others privately told the newspaper that they're worried about Collins' near-evangelistic embrace of religion.

Numerous times, he has publicly recounted his conversion to Christianity as a medical student in his late 20s, the Times reported. More recently, Collins penned a book called "The Language of God."

Others take issue with his leadership of the NIH's Human Genome Project. While Collins was lauded in 2003 when the program succeeded in its goal to map the billions of base pairs that comprise human DNA, some have soured on the accomplishment, saying it hasn't led to "an array of promising medical interventions," the Times reported.

Collins shouldn't shoulder blame for the genetic research industry's failure to come up with quick medical breakthroughs, the newspaper said, adding, "He played an important role in raising expectations impossibly high." Other critics cited the "extraordinary" cost of the project, the Times reported.

Collins has a Ph.D. in physical chemistry from Yale and a medical degree from the University of North Carolina. His confirmation by the U.S. Senate appears likely, the Times said.

The NIH, the world's primary source of medical research funding, is slated to distribute some $37 billion in research grants and spend $4 billion on its own research programs over the next 14 months, the newspaper said.

-----

Swine Flu Vaccine Could Get Scarce: Experts

The United States could find itself short of swine flu vaccine if the virus becomes much more lethal and countries start to scramble for more of the vaccine, experts warn.

They noted that the United States makes only 20 percent of the flu vaccines it uses. The situation is even worse in Britain, which imports all its flu vaccines. Only a few countries are self-sufficient in vaccines.

"This isn't rocket science. If there is more severe disease, countries will want to hang onto the vaccine for their own citizens," Michael Osterholm, director of the Center for Infectious Diseases Research and Policy at the University of Minnesota, told the Associated Press.

Leaders of countries with adequate supplies of swine flu vaccine won't be willing to share with other nations, experts predict.

"Pandemic vaccine will be a valuable and scarce resource, like oil or food during a famine," David Fidler, an Indiana University law professor who has consulted for the World Health Organization, told the AP. "We've seen how countries behave in those situations, and it's not encouraging."